Literature DB >> 18300142

Comparison of Gd-DTPA-induced signal enhancements in rat brain C6 glioma among different pulse sequences in 3-Tesla magnetic resonance imaging.

H Sato1, J Enmi, N Teramoto, T Hayashi, A Yamamoto, T Tsuji, H Naito, H Iida.   

Abstract

BACKGROUND: T1-shortening contrast media are routinely used in magnetic resonance (MR) examinations for the diagnosis of brain tumors. Although some studies show a benefit of 3 Tesla (T) compared to 1.5T in delineation of brain tumors using contrast media, it is unclear which pulse sequences are optimal.
PURPOSE: To compare gadopentetate dimeglumine (Gd-DTPA)-induced signal enhancements in rat brain C6 glioma in the thalamus region among different pulse sequences in 3T MR imaging.
MATERIAL AND METHODS: Five rats with a surgically implanted C6 glioma in their thalamus were examined. T1-weighted brain images of the five rats were acquired before and after Gd-DTPA administration (0.1 mmol/kg) using three clinically available pulse sequences (spin echo [SE], fast SE [FSE], fast spoiled gradient echo [FSPGR]) at 3T. Signal enhancement in the glioma (E(T)) was calculated as the signal intensity after Gd-DTPA administration scaled by that before administration. Pulse sequences were compared using the Tukey-Kramer test.
RESULTS: E(T) was 1.12+/-0.05 for FSE, 1.26+/-0.11 for FSPGR, and 1.20+/-0.11 for SE. FSPGR showed significantly higher signal enhancement than FSE and comparable enhancement to SE.
CONCLUSION: FSPGR is superior to FSE and comparable to SE in its ability to delineate rat brain C6 glioma in the thalamus region.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18300142     DOI: 10.1080/02841850701630326

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  3 in total

1.  Use of a clinical MRI scanner for preclinical research on rats.

Authors:  Akihide Yamamoto; Hiroshi Sato; Jun-ichiro Enmi; Kenji Ishida; Takayuki Ose; Atsuomi Kimura; Hideaki Fujiwara; Hiroshi Watabe; Takuya Hayashi; Hidehiro Iida
Journal:  Radiol Phys Technol       Date:  2008-10-01

Review 2.  Multifunctional micellar nanomedicine for cancer therapy.

Authors:  Elvin Blanco; Chase W Kessinger; Baran D Sumer; Jinming Gao
Journal:  Exp Biol Med (Maywood)       Date:  2008-12-08

3.  Metabolically stable bradykinin B2 receptor agonists enhance transvascular drug delivery into malignant brain tumors by increasing drug half-life.

Authors:  Hemant Sarin; Ariel S Kanevsky; Steve H Fung; John A Butman; Robert W Cox; Daniel Glen; Richard Reynolds; Sungyoung Auh
Journal:  J Transl Med       Date:  2009-05-13       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.